Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FU4XT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,320
Award facts
- Contract value 100% obligated
- $22,319.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract valued at $22,319.75. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of June 27, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award Management. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
This delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen's expansive federal contract portfolio. The company's DLA prime contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its significant contract presence supporting military healthcare systems, positions the company as a primary vendor for the Defense Logistics Agency's pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FU4XT?
SPE2DB25FU4XT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 26, 2025.
How much is contract SPE2DB25FU4XT worth?
The government has obligated $22,320 on SPE2DB25FU4XT.
Is contract SPE2DB25FU4XT an order under another contract?
Yes. SPE2DB25FU4XT is a delivery order under SPE2DB22D2108, an indefinite delivery contract.
Was contract SPE2DB25FU4XT competed?
The extent of competition for SPE2DB25FU4XT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award